GridAI Technologies Corp. (GRDX)
NASDAQ: GRDX · Real-Time Price · USD
4.990
+0.040 (0.81%)
Jun 18, 2026, 12:03 PM EDT - Market open
GridAI Technologies Market Cap
GridAI Technologies has a market cap or net worth of $33.2 million as of June 18, 2026.
Market Cap
33.20M
Enterprise Value
n/a
1-Year Change
n/a
Ranking
Category
Stock Price
$4.99
Market Cap Chart
Since May 28, 2026, GridAI Technologies's market cap has increased from $32.93M to $33.20M, an increase of 0.81%. That is a compound annual growth rate of 16.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 33.86M | 4.73% |
| Jun 15, 2026 | 32.33M | -7.78% |
| Jun 12, 2026 | 35.06M | -10.68% |
| Jun 11, 2026 | 39.25M | 1.90% |
| Jun 10, 2026 | 38.52M | -9.11% |
| Jun 9, 2026 | 42.38M | 2.41% |
| Jun 8, 2026 | 41.38M | -2.05% |
| Jun 5, 2026 | 42.25M | 4.79% |
| Jun 4, 2026 | 40.32M | 2.19% |
| Jun 3, 2026 | 39.45M | -8.35% |
| Jun 2, 2026 | 43.05M | -4.85% |
| Jun 1, 2026 | 45.24M | 21.21% |
| May 29, 2026 | 37.32M | 13.33% |
| May 28, 2026 | 32.93M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CervoMed | 35.28M |
| ABVC BioPharma | 34.67M |
| INmune Bio | 34.56M |
| Grace Therapeutics | 34.35M |
| Aligos Therapeutics | 33.11M |
| Lisata Therapeutics | 32.15M |
| Actinium Pharmaceuticals | 32.00M |
| Boundless Bio | 31.45M |